Auteurs

Matthew Royle, Ph.D.

Associé

Read More

Adrian Toutoungi

Associé

Read More

Paul England, DPhil

Senior professional support lawyer

Read More
Auteurs

Matthew Royle, Ph.D.

Associé

Read More

Adrian Toutoungi

Associé

Read More

Paul England, DPhil

Senior professional support lawyer

Read More

27 juillet 2020 | 39:23

Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents

The Supreme Court's Regeneron Pharmaceuticals Inc v Kymab Ltd decision to revoke two patents for transgenic mouse technology has caused concern to biotech patent owners, especially since the Supreme Court expressed a need to rebalance patent law.

Has this case shifted the boundaries of patent protection, or merely clarified the status quo? What is its context, and broader impact on patents both within and outside the life sciences technology area?

Our experts explain the case and answer these questions in this webinar.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Sciences de la vie et Santé

One Nucleus Genesis Digital 2020 – Key takeaways from our cell and gene therapy panel session

6 janvier 2021
Quick read

par Adrian Toutoungi

Cliquer ici pour en savoir plus
pills
Brevets et innovation

IP: Licensing and insolvency

23 juillet 2020
QUICK READ

par plusieurs auteurs

Cliquer ici pour en savoir plus
woman-with-scientific-model
Sciences de la vie et Santé

Everything biologic and biosimilar in-house counsel need to know about COVID-19

29 avril 2020

par plusieurs auteurs

Cliquer ici pour en savoir plus

Événements connexes